Brian Mann

Find an error

Name:
Organization: University of Sheffield
Department:
Title:
Co-reporter:Helen E. Jesse, Tacita L. Nye, Samantha McLean, Jeffrey Green, Brian E. Mann, Robert K. Poole
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2013 Volume 1834(Issue 9) pp:1693-1703
Publication Date(Web):September 2013
DOI:10.1016/j.bbapap.2013.04.019
•Cytochrome bd-I is a CORM- insensitive heme-protein in E. coli.•The oxygen affinity of the ‘third oxidase’, cytochrome bd-II is low (Km 0.24 μM).•Non-thiol antioxidants do not prevent CO-RM-mediated inhibition of respiration.•N-acetylcysteine reduces the uptake of CORM-2 and CORM-3 by E. coli.Background: CO-releasing molecules (CO-RMs) are potential therapeutic agents, able to deliver CO – a critical gasotransmitter – in biological environments. CO-RMs are also effective antimicrobial agents; although the mechanisms of action are poorly defined, haem-containing terminal oxidases are primary targets. Nevertheless, it is clear from several studies that the effects of CO-RMs on biological systems are frequently not adequately explained by the release of CO: CO-RMs are generally more potent inhibitors than is CO gas and other effects of the molecules are evident. Methods: Because sensitivity to CO-RMs cannot be predicted by sensitivity to CO gas, we assess the differential susceptibilities of strains, each expressing only one of the three terminal oxidases of E. coli — cytochrome bd-I, cytochrome bd-II and cytochrome bo′, to inhibition by CORM-3. We present the first sensitive measurement of the oxygen affinity of cytochrome bd-II (Km 0.24 μM) employing globin deoxygenation. Finally, we investigate the way(s) in which thiol compounds abolish the inhibitory effects of CORM-2 and CORM-3 on respiration, growth and viability, a phenomenon that is well documented, but poorly understood. Results: We show that a strain expressing cytochrome bd-I as the sole oxidase is least susceptible to inhibition by CORM-3 in its growth and respiration of both intact cells and membranes. Growth studies show that cytochrome bd-II has similar CORM-3 sensitivity to cytochrome bo′. Cytochromes bo′ and bd-II also have considerably lower affinities for oxygen than bd-I. We show that the ability of N-acetylcysteine to abrogate the toxic effects of CO-RMs is not attributable to its antioxidant effects, or prevention of CO targeting to the oxidases, but may be largely due to the inhibition of CO-RM uptake by bacterial cells. Conclusions: A strain expressing cytochrome bd-I as the sole terminal oxidase is least susceptible to inhibition by CORM-3. N-acetylcysteine is a potent inhibitor of CO-RM uptake by E. coli. General significance: Rational design and exploitation of CO-RMs require a fundamental understanding of their activity. CO and CO-RMs have multifaceted effects on mammalian and microbial cells; here we show that the quinol oxidases of E. coli are differentially sensitive to CORM-3. This article is part of a Special Issue entitled: Oxygen Binding and Sensing Proteins.
Co-reporter:Brian E. Mann
Organometallics 2012 Volume 31(Issue 16) pp:5728-5735
Publication Date(Web):June 22, 2012
DOI:10.1021/om300364a
The development of CO-releasing molecules, CO-RMs, for medical applications is reviewed from a personal point of view. The review covers the initial discovery of CO-RMs and then concentrates on developments involving the author. The review finishes with suggestions for areas meriting further investigation.
Co-reporter:Lindsay Hewison, Sian H. Crook, Brian E. Mann, Anthony J. H. M. Meijer, Harry Adams, Philip Sawle, and Roberto A. Motterlini
Organometallics 2012 Volume 31(Issue 16) pp:5823-5834
Publication Date(Web):June 18, 2012
DOI:10.1021/om3003637
New CO-releasing molecules, [Fe(CO)3X(S2CNR2)] and [Fe(CO)3I(S2COEt)], are reported. [Fe(CO)3X(S2CNR2)] releases the first two carbonyls rapidly to myoglobin (t1/2 < 1 min) and the third carbonyl more slowly. In the case of [Fe(CO)3I(S2COEt)], only 0.4 mol of CO are lost. [Fe(CO)3Br(S2CNEt2)] has low toxicity. CO loss is much slower from [Fe(CO)2(S2CNR2)2] (R2 = Me2, Et2, (CH2CH2)2O, (CH2CH2)2, (CH2CH2OH)2; t1/2 >24 h) and is not observed from [Fe(CO)2(S2COEt)2]. The mechanism of CO loss was investigated using Gaussian 09 calculations for [Fe(CO)3Br(S2CNMe2)] and [Fe(CO)2(S2CNMe2)2]. The X-ray structures of [Fe(CO)3Br(S2CNMe2)] and [Fe(CO)3I(S2CNEt2)]2I2 were determined.
Co-reporter:Lindsay Hewison, Tony R. Johnson, Brian E. Mann, Anthony J. H. M. Meijer, Philip Sawle and Roberto Motterlini  
Dalton Transactions 2011 vol. 40(Issue 33) pp:8328-8334
Publication Date(Web):15 Jul 2011
DOI:10.1039/C1DT10338E
[Fe(L-cysteinate)2(CO)2]2− is a CO releasing molecule which has low cytotoxicity to RAW264.7 macrophages. It provides an example of CO binding using ligands available to ion channels which use CO as a signalling molecule in the absence of heme. Previous work has shown that this compound consists of five isomers and it was proposed that the two isomers with trans-dicarbonyls are dominant. In this work the isomers are re-assigned and shown to be capable of releasing CO, albeit too slowly to act as a signalling receptor. It is shown that by linking the two L-cysteines together to form [Fe(SCH2CH{CO2H}NHCH2)2(CO)2], only one isomer is isolated.
Co-reporter:Lindsay Hewison, Sian H. Crook, Tony R. Johnson, Brian E. Mann, Harry Adams, Sarah E. Plant, Philip Sawle and Roberto Motterlini  
Dalton Transactions 2010 vol. 39(Issue 38) pp:8967-8975
Publication Date(Web):17 Aug 2010
DOI:10.1039/C0DT00203H
New CO-releasing molecules, CO-RMs, based on indenyl iron carbonyls have been identified. Half-lives for carbon monoxide (CO) release, 1H NMR, 13C NMR, IR, mass spectra, elemental analysis and biological data have been determined for the compounds. Limited correlations have been made between half-lives and ΔG‡ for CO release and spectroscopic parameters, ν(CO) and δ(13CO). X-ray structures have been determined for [Fe(η5-C9H7)(CO)2L][BF4] where L is CO, NCMe, PPh3, P(OPh)3, NC5H5 or 1-methylimidazole. Improved preparations of [Fe(η5-C9H7)(CO)2]2 and [Fe(η5-C9H7)(CO)3][BF4] are reported.
Co-reporter:Brian E. Mann and Roberto Motterlini  
Chemical Communications 2007 (Issue 41) pp:4197-4208
Publication Date(Web):14 Jun 2007
DOI:10.1039/B704873D
The occurrence, role and consequences of CO and NO in biological systems are reviewed. This includes their syntheses by heme oxygenases and NO synthases, their biological targets and the physiological effects of their signals. The use of CO and NO gases in medicine are discussed and methods of delivery are illustrated with particular emphasis on the therapeutic properties of compounds that generate controlled amounts of NO and COin vivo.
Co-reporter:Tony R. Johnson, Brian E. Mann, Ian P. Teasdale, Harry Adams, Roberta Foresti, Colin J. Green and Roberto Motterlini  
Dalton Transactions 2007 (Issue 15) pp:1500-1508
Publication Date(Web):08 Mar 2007
DOI:10.1039/B613629J
The pharmacologically active [Ru(CO)3Cl(glycinate)] is shown to be in equilibrium with [Ru(CO)2(CO2H)Cl(glycinate)]− (isomers) at around pH 3.1 which then at physiological pH reacts with more base to give [Ru(CO)2(CO2)Cl(glycinate)]2− (isomers) or [Ru(CO)2(CO2H)(OH)(glycinate)]− (isomers). The ease with which [Ru(CO)3Cl(glycinate)] reacts with hydroxide results in it producing a solution in water with a pH of around 2 to 2.5 depending on concentration and making its solutions more acidic than those of acetic acid at comparable concentrations. Acidification of [Ru(CO)3Cl(glycinate)] with HCl gives [Ru(CO)3Cl2(NH2CH2CO2H)]. The crystal structures of [Ru(CO)3Cl(glycinate)] and [Ru(CO)3Cl2(NH2CH2CO2Me)] are reported.
Co-reporter:Harry Adams;A. M. Amado;Vitor Félix ;Brian E. Mann ;Jorge Antelo-Martinez;Mike Newell;Paulo J. A. Ribeiro-Claro;Sharon E. Spey;James A. Thomas Dr.
Chemistry - A European Journal 2005 Volume 11(Issue 7) pp:
Publication Date(Web):26 JAN 2005
DOI:10.1002/chem.200400693

The synthesis of a series of RuII complexes incorporating thiacrown ligands ([12]ane-S4, [14]ane-S4, [16]ane-S4), as well as 2,2′-bipyridine (bpy) or pyridine, is reported. Structural studies on these complexes have been carried out using a variety of techniques. Detailed 1H NMR spectroscopic studies on the previously reported [Ru([12]ane-S4)(bpy)]2+ (1) reveal that—contrary to earlier reports—the observed fluxional 1H NMR behavior is not due to chemical exchange involving cleavage of the bpy RuN bond but is, in fact, due to lone-pair inversion of coordinated macrocyclic sulfur donor atoms. This phenomenon is also observed for the [14]ane-S4 and [16]ane-S4 analogues of 1. For the first time, using a combination of X-ray crystallography, more detailed 1H NMR experiments, and computational methods, an in-depth study on the energetics and dynamics of invertomer formation and conversion for macrocyclic coordination complexes has been carried out. These studies reveal that the steric constraints of assembling each sulfur macrocycle and bpy ligand around the octahedral RuII center lead to close intramolecular contacts. These contacts are largely dependent on the orientation of the electron lone pairs of equatorial sulfur donor atoms and correlate with the comparative stability of the different invertomeric forms. Thus, the conformational preferences of the three macrocyles in [Ru([n]ane-S4)(bpy)]2+ complexes are determined by steric rather than electronic effects.

Co-reporter:Tony R. Johnson;Brian E. Mann ;James E. Clark;Roberta Foresti;Colin J. Green ;Roberto Motterlini Dr.
Angewandte Chemie 2003 Volume 115(Issue 32) pp:
Publication Date(Web):13 AUG 2003
DOI:10.1002/ange.200301634

Mittlerweile steht fest, dass NO trotz seiner hohen Toxizität in Säugetieren als Botenstoff fungiert. Da NO+ und CO isoelektronisch sind, sollte es nicht überraschen, dass CO eine gleichartige Funktion zukommt. Der Mensch produziert selbst etwa 3–6 cm3 CO pro Tag, wobei bestimmte Entzündungszustände sowie pathologische Bedingungen, die mit der Hämolyse der roten Blutkörperchen verbunden sind, die produzierte Menge merklich erhöhen. In den letzten zehn Jahren ist das Interesse an den biologischen Wirkungen von CO stark gestiegen und inzwischen gilt es in der medizinischen Literatur als gesichert, dass CO in Säugetieren eine wesentliche Rolle als Signalmolekül spielt. Dabei ist der Hauptwirkungsbereich das Herz-Kreislauf-System, z. B. bei der Unterdrückung von Abstoßungsreaktionen bei Organtransplantationen und beim Schutz des Gewebes vor ischämischer Schädigung und Apoptose. Vor kurzem wurde gezeigt, dass Carbonylmetallkomplexe im Organismus CO freisetzen und ähnliche biologische Wirkungen wie CO selbst zeigen können. Dies eröffnet die Möglichkeit, pharmazeutisch wichtige Carbonylmetallkomplexe zu entwickeln.

Co-reporter:Tony R. Johnson;Brian E. Mann ;James E. Clark;Roberta Foresti;Colin J. Green ;Roberto Motterlini Dr.
Angewandte Chemie International Edition 2003 Volume 42(Issue 32) pp:
Publication Date(Web):13 AUG 2003
DOI:10.1002/anie.200301634

It is now established that NO is a messenger molecule in mammals despite its high toxicity. As NO+ and CO are isoelectronic, it should not be unexpected that CO could also have a role as a messenger. CO is produced naturally in humans at a rate of between 3 and 6 cm3 per day, and this rate is increased markedly by certain inflammatory states and pathological conditions associated with red blood cell hemolysis. Over the last 10 years, the interest in the biological effects of CO has greatly increased, and it is now established in the medical literature that CO does have a major role as a signaling molecule in mammals. It is particularly active within the cardiovascular system, for example, in suppressing organ graft rejection and protecting tissues from ischemic injury and apoptosis. Recently it has been shown that metal carbonyls can also function as CO-releasing molecules and provide similar biological activities. This opens the possibility to develop pharmaceutically important metal carbonyls.

Co-reporter:Harry Adams, Sylvana C.M Agustinho, Brian E Mann, Stephen Smith
Journal of Organometallic Chemistry 2000 Volume 607(1–2) pp:175-181
Publication Date(Web):11 August 2000
DOI:10.1016/S0022-328X(00)00335-1
The crystal structure of [Fe3(CO)10(dppe)] has been determined. The Ph2PCH2CH2PPh2 ligand bridges the Fe(μ-CO)2Fe edge and is markedly non-planar. The non-planarity inverts with ΔG‡211=48.4±0.5 kJ mol−1. The carbonyls on the bridged iron atoms exchange with the axial ones by the merry-go-round mechanism with ΔG‡195=43.4±0.5 kJ mol−1. Despite the non-planar dppe ligand producing a chiral molecule, the merry-go-round exchange goes with equal rate in both directions. This is the first example of a six-toothed failed ratchet.
Co-reporter:Sarah Fayad-Kobeissi, Johary Ratovonantenaina, Hubert Dabiré, Jayne Louise Wilson, Anne Marie Rodriguez, Alain Berdeaux, Jean-Luc Dubois-Randé, Brian E. Mann, Roberto Motterlini, Roberta Foresti
Biochemical Pharmacology (15 February 2016) Volume 102() pp:
Publication Date(Web):15 February 2016
DOI:10.1016/j.bcp.2015.12.014
Carbon monoxide (CO) is generated by heme oxygenase-1 (HO-1) and displays important signaling, anti-apoptotic and anti-inflammatory activities, indicating that pharmacological agents mimicking its action may have therapeutic benefit. This study examined the biochemical and pharmacological properties of CORM-401, a recently described CO-releasing molecule containing manganese as a metal center. We used in vitro approaches, ex-vivo rat aortic rings and the EA.hy926 endothelial cell line in culture to address how CORM-401 releases CO and whether the compound modulates vascular tone and pro-angiogenic activities, respectively. We found that CORM-401 released up to three CO/mole of compound depending on the concentration of the acceptor myoglobin. Oxidants such as H2O2, tert-butyl hydroperoxide or hypochlorous acid increased the CO liberated by CORM-401. CORM-401 also relaxed pre-contracted aortic rings and vasorelaxation was enhanced in combination with H2O2. Consistent with the release of multiple CO molecules, CORM-401-induced vasodilation was three times higher than that elicited by CORM-A1, which exhibits a similar half-life to CORM-401 but liberates only one CO/mole of compound. Furthermore, endothelial cells exposed to CORM-401 accumulated CO intracellularly, accelerated migration in vitro and increased VEGF and IL-8 levels. Studies using pharmacological inhibitors revealed HO-1 and p38 MAP kinase as two independent and parallel mechanisms involved in stimulating migration. We conclude that the ability of CORM-401 to release multiple CO, its sensitivity to oxidants which increase CO release, and its vascular and pro-angiogenic properties highlight new advances in the design of CO-releasing molecules that can be tailored for the treatment of inflammatory and oxidative stress-mediated pathologies.
Co-reporter:David Scapens, Harry Adams, Tony R. Johnson, Brian E. Mann, Philip Sawle, Rehan Aqil, Trevor Perrior and Roberto Motterlini
Dalton Transactions 2007(Issue 43) pp:NaN4973-4973
Publication Date(Web):2007/09/19
DOI:10.1039/B704832G
A new group of CO-releasing molecules, CO-RMs, based on cyclopentadienyl iron carbonyls have been identified. X-Ray structures have been determined for [(η-C5H4CO2Me)Fe(CO)2X], X = Cl, Br, I, NO3, CO2Me, [(η-C5H4CO2Me)Fe(CO)2]2, [(η-C5H4CO2CH2CH2OH)Fe(CO)2]2 and [(η-C5H4CO2Me)Fe(CO)3][FeCl4]. Half-lives for CO release, 1H, 13C, and 17OC NMR and IR spectra have been determined along with some biological data for these compounds, [(η-C5H4CO2CH2CH2OH)Fe(CO)3]+ and [{η-C5H4(CH2)nCO2Me}Fe(CO)3]+, n = 1, 2. More specifically, cytotoxicity assays and inhibition of nitrite formation in stimulated RAW264.7 macrophages are reported for most of the compounds analyzed. [(η-C5H5)Fe(CO)2X], X = Cl, Br, I, were also examined for comparison. Correlations between the half-lives for CO release and spectroscopic parameters are found within each group of compounds, but not between the groups.
Co-reporter:Tony R. Johnson, Brian E. Mann, Ian P. Teasdale, Harry Adams, Roberta Foresti, Colin J. Green and Roberto Motterlini
Dalton Transactions 2007(Issue 15) pp:NaN1508-1508
Publication Date(Web):2007/03/08
DOI:10.1039/B613629J
The pharmacologically active [Ru(CO)3Cl(glycinate)] is shown to be in equilibrium with [Ru(CO)2(CO2H)Cl(glycinate)]− (isomers) at around pH 3.1 which then at physiological pH reacts with more base to give [Ru(CO)2(CO2)Cl(glycinate)]2− (isomers) or [Ru(CO)2(CO2H)(OH)(glycinate)]− (isomers). The ease with which [Ru(CO)3Cl(glycinate)] reacts with hydroxide results in it producing a solution in water with a pH of around 2 to 2.5 depending on concentration and making its solutions more acidic than those of acetic acid at comparable concentrations. Acidification of [Ru(CO)3Cl(glycinate)] with HCl gives [Ru(CO)3Cl2(NH2CH2CO2H)]. The crystal structures of [Ru(CO)3Cl(glycinate)] and [Ru(CO)3Cl2(NH2CH2CO2Me)] are reported.
Co-reporter:Lindsay Hewison, Tony R. Johnson, Brian E. Mann, Anthony J. H. M. Meijer, Philip Sawle and Roberto Motterlini
Dalton Transactions 2011 - vol. 40(Issue 33) pp:NaN8334-8334
Publication Date(Web):2011/07/15
DOI:10.1039/C1DT10338E
[Fe(L-cysteinate)2(CO)2]2− is a CO releasing molecule which has low cytotoxicity to RAW264.7 macrophages. It provides an example of CO binding using ligands available to ion channels which use CO as a signalling molecule in the absence of heme. Previous work has shown that this compound consists of five isomers and it was proposed that the two isomers with trans-dicarbonyls are dominant. In this work the isomers are re-assigned and shown to be capable of releasing CO, albeit too slowly to act as a signalling receptor. It is shown that by linking the two L-cysteines together to form [Fe(SCH2CH{CO2H}NHCH2)2(CO)2], only one isomer is isolated.
Co-reporter:Brian E. Mann;Roberto Motterlini
Chemical Communications 2007(Issue 41) pp:NaN4208-4208
Publication Date(Web):2007/10/17
DOI:10.1039/B704873D
The occurrence, role and consequences of CO and NO in biological systems are reviewed. This includes their syntheses by heme oxygenases and NO synthases, their biological targets and the physiological effects of their signals. The use of CO and NO gases in medicine are discussed and methods of delivery are illustrated with particular emphasis on the therapeutic properties of compounds that generate controlled amounts of NO and COin vivo.
Co-reporter:Lindsay Hewison, Sian H. Crook, Tony R. Johnson, Brian E. Mann, Harry Adams, Sarah E. Plant, Philip Sawle and Roberto Motterlini
Dalton Transactions 2010 - vol. 39(Issue 38) pp:NaN8975-8975
Publication Date(Web):2010/08/17
DOI:10.1039/C0DT00203H
New CO-releasing molecules, CO-RMs, based on indenyl iron carbonyls have been identified. Half-lives for carbon monoxide (CO) release, 1H NMR, 13C NMR, IR, mass spectra, elemental analysis and biological data have been determined for the compounds. Limited correlations have been made between half-lives and ΔG‡ for CO release and spectroscopic parameters, ν(CO) and δ(13CO). X-ray structures have been determined for [Fe(η5-C9H7)(CO)2L][BF4] where L is CO, NCMe, PPh3, P(OPh)3, NC5H5 or 1-methylimidazole. Improved preparations of [Fe(η5-C9H7)(CO)2]2 and [Fe(η5-C9H7)(CO)3][BF4] are reported.
sodium dithionate
CORM-3
Ferrate(2-), [7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-κN21,κN22,κN23,κN24]-, hydrogen (1:2), (SP-4-2)-